🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
DNA
$DNA
🔒 US EquitiesGinkgo Bioworks Holdings
AVG HISTORICAL GAP
-4.54%
MAX GAP RECORD
-17.55%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $DNA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$DNA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE) |
-2.56%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
-16.18%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE) |
-17.55%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
-8.94%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE) |
+4.38%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
+5.89%
|
| Feb 25, 2025 Earnings Release 2025-02-25 (AFTER CLOSE) |
-14.29%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
+8.34%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
8.4%
Bullish Gaps (5)
Bearish Gaps (10)
Neutral / Flat (0)
📖 Intelligence Summary
Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗